Contineum Therapeutics, Inc. (CTNM)
11.55
-0.03
(-0.26%)
USD |
NASDAQ |
Dec 16, 16:00
11.77
+0.22
(+1.90%)
After-Hours: 20:00
Contineum Therapeutics Total Liabilities (Quarterly): 10.38M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | 129.42M |
| Recursion Pharmaceuticals, Inc. | 352.58M |
| CG Oncology, Inc. | 42.27M |
| CEL-SCI Corp. | 13.31M |
| AIM ImmunoTech, Inc. | 11.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 190.85M |
| Shareholders Equity (Quarterly) | 180.47M |
| Debt to Equity Ratio | 0.0304 |
| Current Ratio | 29.07 |
| Net Debt Paydown Yield | -0.32% |